Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancers. | Genome Med | 2023 | 38008725 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas. | J Immunother Cancer | 2023 | 38007239 | PubTator, text mining | PubMed |
| The Promotion of Humoral Immune Responses in Humans via SOCS1-Mediated Th2-Bias Following SARS-CoV-2 Vaccination. | Vaccines (Basel) | 2023 | 38006062 | PubTator, text mining | PubMed |
| Generation of a Novel SORT1×HER2 Bispecific Antibody-Drug Conjugate Targeting HER2-Low-Expression Tumor. | Int J Mol Sci | 2023 | 38003245 | PubTator, text mining | PubMed |
| Lysosomal-Cleavable Peptide Linkers in Antibody-Drug Conjugates. | Biomedicines | 2023 | 38002080 | PubTator, text mining | PubMed |
| Changing Trends in B-Cell Non-Hodgkin Lymphoma Treatment: The Role of Novel Monoclonal Antibodies in Clinical Practice. | Cancers (Basel) | 2023 | 38001657 | PubTator, text mining | PubMed |
| Primary breast diffuse large B-cell lymphoma in the rituximab era: A retrospective study of the Chinese Southwest Oncology Group. | Cancer Med | 2023 | 37997571 | PubTator, text mining | PubMed |
| The extrafollicular B cell response is a hallmark of childhood idiopathic nephrotic syndrome. | Nat Commun | 2023 | 37996443 | PubTator, text mining | PubMed |
| Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignancies. | Sci Rep | 2023 | 37989777 | PubTator, text mining | PubMed |
| Trends in the Development of Antibody-Drug Conjugates for Cancer Therapy. | Antibodies (Basel) | 2023 | 37987250 | PubTator, text mining | PubMed |
| Lymphoma of the central nervous system originating from the septum pellucidum region: Two case reports with literature review. | Medicine (Baltimore) | 2023 | 37986283 | PubTator, text mining | PubMed |
| Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer. | Sci Data | 2023 | 37985782 | PubTator, text mining | PubMed |
| Vaccines for immune tolerance against autoimmune disease. | Adv Drug Deliv Rev | 2023 | 37980949 | PubTator, text mining | PubMed |
| Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myeloma. | Nat Commun | 2023 | 37980341 | PubTator, text mining | PubMed |
| Next-Generation Sequencing of Vitreoretinal Lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation. | Invest Ophthalmol Vis Sci | 2023 | 37975847 | PubTator, text mining | PubMed |
| A big STEP (Simultaneous Tumor and Effector Profiling) forward in the battle against chimeric antigen receptor (CAR) T-cell therapy resistance. | Transl Cancer Res | 2023 | 37969398 | PubTator, text mining | PubMed |
| Single cell transcriptomics shows that malaria promotes unique regulatory responses across multiple immune cell subsets. | Nat Commun | 2023 | 37968278 | PubTator, text mining | PubMed |
| Comprehensive analysis of HDAC7 expression and its prognostic value in diffuse large B cell lymphoma: A review. | Medicine (Baltimore) | 2023 | 37960766 | PubTator, text mining | PubMed |
| Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus: A Consequence of Patient-Intrinsic or -Extrinsic Factors? | J Clin Med | 2023 | 37959410 | PubTator, text mining | PubMed |
| T-Cell Engaging Antibodies in Diffuse Large B Cell Lymphoma-An Update. | J Clin Med | 2023 | 37959202 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=20